CAPR Securities Losses: Capricor Therapeutics Investors with Losses on their Investment are Reminded to Contact BFA Law by September 28 Deadline in Securities Fraud Class Action

Capricor Therapeutics investors are being reminded of a September 28 deadline to contact BFA Law regarding a securities-fraud class action. The notice signals potential litigation exposure and investor-loss claims, creating a negative overhang for the biotech company's shares, though the article provides no alleged damages, operational metrics, or case details.